Doseloop Beta

Proton pump inhibitors

medication Under review

Proton pump inhibitors, or PPIs, are a class of prescription and over-the-counter medications that reduce stomach acid by blocking the gastric proton pump in the cells that line the stomach. Common examples include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. They are widely used for acid reflux, gastroesophageal reflux disease, peptic ulcers, and other acid-related conditions. By lowering acid production, PPIs can relieve heartburn, protect the esophagus from acid injury, and help heal ulcers. In healthy people, short-term use is generally well tolerated, but PPIs also change the stomach and intestinal environment, which can alter the gut microbiome and downstream digestion-related processes. Because of this, they are often discussed in the context of gut health, though they are not a dietary supplement and are typically used as medications rather than as nutrients.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

In healthy human studies, PPIs have been used as a tool to examine how suppressing stomach acid affects the gut microbiome and metabolome. The main finding is that PPIs can measurably alter microbial composition and metabolic profiles in otherwise healthy volunteers, supporting the idea that acid suppression has downstream effects on gut ecology. Overall, the evidence in healthy subjects is limited and mostly mechanistic rather than outcome-focused. Short-term use appears generally safe, with common side effects being mild gastrointestinal symptoms or headaches, but the strongest human evidence in healthy participants relates to changes in gut bacteria rather than proven clinical benefits for wellness.

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (2 studies)

Preliminary

Real-World Infectious Outcomes with Dupilumab Compared with Proton Pump Inhibitors and Topical Steroids in Eosinophilic Esophagitis: A Multi-cohort Propensity Matched Analysis.

StatPearls • 2025

StatPearls editors

Systematic Review

Review of the Long-Term Effects of Proton Pump Inhibitors

Current Gastroenterology Reports • 2017

Freedberg DE, Kim LS, Yang YX

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 2
Researched benefits 0
Side effects noted 5